Xoxe 250mg Tablet contains Cefuroxime, a second-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. Cefuroxime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The 250mg dosage is typically prescribed based on the severity and type of infection, patient age, renal function, and clinical response. Xoxe 250mg is administered orally and is well absorbed from the gastrointestinal tract, with peak plasma concentrations achieved within 2 to 3 hours post-dose. It is important to complete the full prescribed course to prevent the development of resistance. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, as well as hypersensitivity reactions in patients with a history of penicillin or cephalosporin allergy. Caution is advised in patients with renal impairment, and dose adjustment may be necessary. Xoxe 250mg should be used under medical supervision, with periodic monitoring for efficacy and safety.